Exploring the therapeutic efficacy of Chlorella pyrenoidosa peptides in ameliorating Alzheimer's disease

Pharmacology, Toxicology and Pharmaceutical Science

• Peptide 100%
• Chlorella pyrenoidosa 100%
• Combination Therapy 100%
• Alzheimer's Disease 100%
• Neurofibrillary Tangle 75%
• Disease 50%
• Amyloid 50%
• Survival Rate 25%
• Cognitive Defect 25%
• Tumor Necrosis Factor 25%
• Disease Exacerbation 25%
• Mouse Model 25%
• Cytokine 25%
• Anti-Inflammatory Drug 25%
• Injury 25%
• Amnesia 25%
• Brain Atrophy 25%
• Chlorella 25%
• Neuroprotective Agent 25%
• Glutamic Acid 25%
• Degenerative Disease 25%

Neuroscience

• Peptide 100%
• Alzheimer's Disease 100%
• In Vivo 50%
• Neurodegenerative Disorder 50%
• In Vitro 50%
• Cognitive Disorders 25%
• Neuroprotective Agent 25%
• Glutamic Acid 25%
• Anti-Inflammatory 25%
• Cell Loss 25%
• Neuroapoptosis 25%
• Beta Amyloid 25%
• Amnesia 25%
• Amyloid 25%
• Long-Term Memory 25%
• Cell Damage 25%